Dragan Grabulovski
Chief Executive Officer Araris Biotech
Dragan is a co-founder and CEO of Araris. He has been a member of the company’s board of directors since its inception. Prior to this role, he worked as a biotech consultant, advising numerous venture capital firms and biotech companies, and served as a start-up coach for ETH Zurich and Innosuisse. From 2007 to 2014, he was the co-founder and CSO of Covagen, a Swiss biotech company that was acquired in 2014 by an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson. Dragan holds a Master’s degree and a PhD in Pharmaceutical Sciences from ETH Zurich.
Seminars
Tuesday 9th March 2027
CEO & ADC Pharma Leaders Think Tank: Solidifying Next Generation ADCs as Standard of Care Therapies
9:30 am
- Understanding the 2027 ADC landscape and how the bar has been raised to develop and deliver ADCs with meaningful patient impact
- Outlining the future opportunities and applications on the horizon for ADCs to achieve target differentiation and clinical safety
- Highlighting methods to best pursue ADC clinical differentiation across patient selection technologies, combination strategies, and well-executed clinical design
- With clinical trials advancing in the Far East and Australia, what opportunities does this open for the ADC industry to progress faster?
